Michael John Tomsicek, Chief Financial Officer

CRSP 410 shares

The estimated Net Worth of Michael John Tomsicek is at least $35,806.53. Michael John Tomsicek owns over 410 units of CRISPR Therapeutics AG stock worth over $35,806.53.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
3rd August 2020CRSP - CRISPR Therapeutics AG5,448Open or private sale410$87.33$475,790.18$35,806.53
3rd August 2020CRSP - CRISPR Therapeutics AG6,552Open or private sale5,858$86.25$565,128.35$505,268.90
3rd August 2020CRSP - CRISPR Therapeutics AG12,000Exercise of derivative12,410$17.75$213,000.00$220,277.50
1st September 2020CRSP - CRISPR Therapeutics AG2,800Open or private sale410$93.18$260,904.00$38,203.80
1st September 2020CRSP - CRISPR Therapeutics AG6,400Open or private sale3,210$92.23$590,272.00$296,058.30
1st September 2020CRSP - CRISPR Therapeutics AG2,800Open or private sale9,610$91.39$255,892.00$878,257.90
1st September 2020CRSP - CRISPR Therapeutics AG12,000Exercise of derivative12,410$17.75$213,000.00$220,277.50